Medical/Pharmaceuticals
Connected pen injector add-on designed by SHL Medical wins 2021 Good Design Award
ZUG, Switzerland, Feb. 24, 2022 /PRNewswire/ -- SHL Medical and Innovation Zed is pleased to share the news that Innovation Zed's injection time-tracker connected device, the InsulCheck CONNECT, a device that was designed by SHL Medical, has been selected as a winner of the 2021 Good Design Award...
2022-02-24 15:00
3288
Sino Group and Ng Teng Fong Charitable Foundation Partner with HKCSS and Social Welfare Department to Distribute 500 Belun(R) remoVital Remote Monitoring Systems to Care Homes
HONG KONG, Feb. 24, 2022 /PRNewswire/ -- Sino Group and the Ng Teng Fong Charitable Foundation, its philanthropic arm, are partnering with the Hong Kong Council of Social Service (HKCSS) and the Social Welfare Department to distribute 500 Belun® remoVital remote monitoring systems to residential ...
2022-02-24 14:26
4373
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer
HONG KONG, Feb. 24, 2022 /PRNewswire/ -- On February 23 2022, Simcere Pharmaceutical Group (2096.HK) announced that the phase III clinical registration study of Trilaciclib in patients with extensive-stage small cell lung cancer (ES-SCLC) has met its primary endpoint. The drug co-developed in Chi...
2022-02-24 13:34
2450
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China
BEIJING, SHANGHAI and BOSTON, Feb. 23, 2022 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combinationtherapy with Cetuximab at Peking University Cancer Hospital recently. JAB-21822 in combination with ce...
2022-02-24 10:32
2410
Alphamab Oncology Announced Publication of Clinical Results of KN026 in HER2-positive Breast Cancer in Clinical Cancer Research
SUZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announcedClinical Cancer Research, a journal of the American Association for Cancer Research (AACR), published the data from a phase I clinical study of the company's proprietary HER2 bispecific antibody KN026 fo...
2022-02-24 09:41
3499
Innovent Announces First Patient Dosed with CD73 Antibody in Phase 1a/1b Clinical Trial for Advanced Solid Tumor
SAN FRANCISCO and SUZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2022-02-24 08:00
4756
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement
TAIPEI, Feb. 23, 2022 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), aTaiwan and US-based biopharmaceutical company and TRPharm, a leading Turkish healthcare company, announced today that they have entered into an exclusive license agreement for the co-development and ...
2022-02-23 23:00
3109
Orpha Labs AG Announces the Initiation of a Phase III Trial Evaluating ORL-101 for Treatment of Leukocyte Adhesion Deficiency Type II
BAAR, Switzerland, Feb. 23, 2022 /PRNewswire/ -- Orpha Labs AG, a clinical-stage biopharmaceutical company focused on diseases with unmet needs, today announced the initiation of the Phase III trial with ORL-101 in patients with Leukocyte Adhesion Deficiency Type II ("LAD-II"). Orpha Labs AG is w...
2022-02-23 21:27
3847
Identi Medical Wins the Frost & Sullivan Product Innovation Award for Increasing Inventory Visibility in Operating Rooms Using Image Recognition
Identi Medical helps hospitals provide safer care for their patients with its highly differentiated inventory management solutions for operating and procedural rooms SAN ANTONIO, Feb. 23, 2022 /PRNewswire/ -- Based on its recent analysis of the European Operating Room Inventory Management Soluti...
2022-02-23 21:00
2470
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial result...
2022-02-23 20:00
3031
Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced interim data from a Phase II clinical trial of STP705, a siRNA (small interfering RNA) therapeutic, ...
2022-02-23 17:53
3897
Simcere Pharma (2096.HK) Announces a Positive Profit Alert
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (the "Company", together with its subsidiaries, the "Group"; stock code: 2096.HK), announces a positive profit alert. Based on a preliminary assessment of the Group's unaudited consolidated management accounts for the ...
2022-02-23 16:22
4102
Citadel Health: Pandemic highlights data revolution urgency
LONDON, Feb. 23, 2022 /PRNewswire/ -- David Wells, the biomedical scientist who spearheaded NHS England's COVID-19 testing response, says the pandemic's scale and impact highlights the urgent need to reshape diagnostics worldwide. Mr Wells led the NHS drive to build a nationwide testing service f...
2022-02-23 14:53
2322
The journey from Good to Great: Camly Academy successfully launched in the U.S market
HO CHI MINH CITY, Vietnam, Feb. 23, 2022 /PRNewswire/ -- Recently, Camly Academy of Camly Group successfully held an event to launch an educational platform in the US market with the topic: "Self-Education for Happiness: Good to Great" onFebruary 22, 2022 to announce action mission towards sustai...
2022-02-23 14:49
3122
Radiaction Opens First EU Radiation Protection Center of Excellence in Collaboration with Mazowiecki Hospital in Ostrołęka, Poland
TEL AVIV, Israel, Feb. 22, 2022 /PRNewswire/ -- Radiaction Medical Ltd
2022-02-23 10:00
3223
Havas Health & You Announces Expansion Across APAC, Including Southeast Asia (SEA) Village
SINGAPORE, Feb. 23, 2022 /PRNewswire/ -- In the next decade, APAC will represent 40% of total growth in global health spending, expanding at a rate almost double that of the rest of the world – making both presence and investment in APAC more critical than ever. To help Havas Health & You (HH&Y) ...
2022-02-23 09:00
2464
XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic System
The XACT ACE® Robotic System addresses the limitations of traditional manual methods and other image-guided percutaneous intervention systems. SAN ANTONIO, Feb. 22, 2022 /PRNewswire/ -- Frost & Sullivan recently evaluated the North American percutaneous procedure system industry and, based on it...
2022-02-22 23:00
2613
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution
BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement withHiroshima University, one of the top public universities inHiroshima City, Japan, to support their molecular profiling by next-generation sequencing ...
2022-02-22 20:57
3369
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company
SEOUL, South Korea, Feb. 22, 2022 /PRNewswire/ -- RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest global pharmaceutical companies Eli Lilly and Company (hereinafter referred to as "Eli Lilly...
2022-02-22 20:52
4845
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform
SUZHOU, China, and PALO ALTO, Calif., Feb. 22, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...
2022-02-22 20:30
2809
Week's Top Stories
Most Reposted
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
55378
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
48420
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
36483
